Raymond James Financial Services Advisors, Inc. Abiomed Inc Transaction History

Raymond James Financial Services Advisors, Inc.

$73.5 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 25, 2022	SELL	$242.49 - $301.46 $56,257 - $69,938	-232 Reduced 16.79%	1,150 $283,000
Q2 2022 Aug 12, 2022	BUY	$224.73 - $338.64 $47,418 - $71,453	211 Added 18.02%	1,382 $342,000
Q1 2022 May 11, 2022	SELL	$277.25 - $366.29 $4.7 Million - $6.21 Million	-16,961 Reduced 93.54%	1,171 $388,000
Q4 2021 Feb 08, 2022	BUY	$300.63 - $371.35 $177,972 - $219,839	592 Added 3.38%	18,132 $6.51 Million
Q3 2021 Nov 02, 2021	BUY	$310.19 - $376.2 $2.93 Million - $3.55 Million	9,444 Added 116.65%	17,540 $5.71 Million
Q2 2021 Aug 11, 2021	BUY	$262.71 - $351.17 $122,685 - $163,996	467 Added 6.12%	8,096 $2.53 Million
Q1 2021 May 14, 2021	BUY	$285.92 - $355.13 $322,231 - $400,231	1,127 Added 17.33%	7,629 $2.43 Million
Q4 2020 Feb 12, 2021	SELL	$251.88 - $324.2 $3.58 Million - $4.6 Million	-14,199 Reduced 68.59%	6,502 $2.11 Million
Q3 2020 Nov 04, 2020	BUY	$255.22 - $317.0 $3.78 Million - $4.7 Million	14,820 Added 252.0%	20,701 $5.74 Million
Q2 2020 Jul 17, 2020	BUY	$141.4 - $257.09 $150,025 - $272,772	1,061 Added 22.01%	5,881 $1.42 Million
Q1 2020 Apr 21, 2020	BUY	$130.51 - $196.01 $94,097 - $141,323	721 Added 17.59%	4,820 $700,000
Q4 2019 Feb 12, 2020	SELL	$159.31 - $223.54 $128,403 - $180,173	-806 Reduced 16.43%	4,099 $699,000
Q3 2019 Nov 07, 2019	SELL	$175.89 - $279.23 $151,089 - $239,858	-859 Reduced 14.9%	4,905 $873,000
Q2 2019 Aug 06, 2019	SELL	$250.96 - $284.94 $721,760 - $819,487	-2,876 Reduced 33.29%	5,764 $1.5 Million
Q1 2019 May 06, 2019	BUY	$276.39 - $362.25 $782,736 - $1.03 Million	2,832 Added 48.76%	8,640 $2.47 Million
Q4 2018 Feb 11, 2019	SELL	$281.08 - $444.25 $702,418 - $1.11 Million	-2,499 Reduced 30.08%	5,808 $1.89 Million
Q3 2018 Nov 14, 2018	SELL	$354.53 - $449.75 $1.86 Million - $2.36 Million	-5,252 Reduced 38.73%	8,307 $3.74 Million
Q2 2018 Jul 30, 2018	BUY	$278.07 - $446.21 $930,700 - $1.49 Million	3,347 Added 32.78%	13,559 $5.55 Million
Q1 2018 Apr 16, 2018	BUY	$192.49 - $295.85 $1.27 Million - $1.96 Million	6,617 Added 184.06%	10,212 $2.97 Million
Q4 2017 Feb 09, 2018	BUY	$168.78 - $199.74 $283,887 - $335,962	1,682 Added 87.92%	3,595 $674,000
Q3 2017 Oct 26, 2017	SELL	$145.39 - $168.6 $21,372 - $24,784	-147 Reduced 7.14%	1,913 $323,000
Q2 2017 Aug 15, 2017	BUY	N/A	2,060	2,060 $295,000

Others Institutions Holding ABMD

# of Institutions

Shares Held

137K

Call Options Held

Put Options Held

View Full List

About ABIOMED INC

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

More about ABMD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Financial Services Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Financial Services Advisors, Inc. with notifications on news.

Account